NET PROFIT (x1000 EUR)
EMPLOYEES
Biocrine AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
3
|
1 |
| Earnings before taxes |
-883
|
-669
|
-830 |
| EBITDA |
-889
|
-667
|
-688 |
| Total assets |
1,198
|
1,896
|
1,333 |
| Current assets |
38
|
856
|
291 |
| Current liabilities |
327
|
147
|
70 |
| Equity capital |
871
|
1,750
|
1,263 |
| - share capital |
26
|
24
|
26 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
72.7%
|
92.3%
|
94.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-73.7%
|
-35.1%
|
-62.2% |
| Current ratio |
11.6%
|
582.3%
|
415.7% |
| Return on equity (ROE) |
-101.4%
|
-38.2%
|
-65.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-11% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.